| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $237.3M | +6.6% |
| Cost of Revenue | $133.4M | +5.9% |
| Gross Profit | $103.9M | +7.6% |
| R&D Expense | $15.7M | -6.7% |
| SG&A Expense | $120.1M | +23.1% |
| Operating Income | -$31.9M | -78.9% |
| Interest Expense | $6.1M | +31.0% |
| Pre-tax Income | -$35.1M | +87.2% |
| Income Tax | $2.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.6M | -73.7% |
| Short-term Investments | $486.7M | -0.6% |
| Accounts Receivable | $43.9M | +11.3% |
| Inventory | $27.7M | +67.7% |
| Current Assets | $604.2M | -12.9% |
| Total Assets | $1.04B | -6.7% |
| Current Liabilities | $40.9M | -4.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.9M | -122.8% |
| Capital Expenditures | $22.1M | -7.4% |
| Investing Cash Flow | -$59.7M | +87.3% |
| Financing Cash Flow | -$39.2M | -106.9% |
| Free Cash Flow | -$24.0M | -52.1% |
| +32.8% |
| Net Income | -$37.3M | +86.5% |
| EPS (Basic) | -$0.93 | +85.0% |
| EPS (Diluted) | -$0.93 | +85.0% |
| Total Liabilities |
| $482.9M |
| +2.5% |
| Stockholders' Equity | $555.8M | -13.4% |